<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Elektra Health — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>

<header class="site-header">
  <h1>Prospect Detail</h1>
</header>

<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>

  <div class="detail-header">
    <span class="badge health" style="font-size:.8rem;">Digital Health</span>
    <h1>31. Elektra Health</h1>
    <p class="meta">Menopause Healthcare Platform</p>
  </div>

  <div class="section">
    <h3>1. Startup Name</h3>
    <p><strong>Elektra Health</strong></p>
  </div>

  <div class="section">
    <h3>2. Founder Contact</h3>
    <p><strong>Jannine Versi</strong> — Co-Founder & CEO</p>
    <p>Harvard Business School MBA '14</p>
    <p>Previously at McKinsey and Progyny</p>
  </div>

  <div class="section">
    <h3>3. Product Overview</h3>
    <p>Elektra Health is a comprehensive menopause healthcare platform offering virtual care, education, and community support. The platform connects women with menopause-trained clinicians for personalized treatment plans, including hormone therapy consultations, and provides evidence-based resources for navigating perimenopause and menopause.</p>
  </div>

  <div class="section">
    <h3>4. Funding Stage</h3>
    <p><strong>Seed</strong> — Raised $3.3M from Seven Seven Six (Alexis Ohanian), Flare Capital Partners, and UPMC Enterprises.</p>
  </div>

  <div class="section">
    <h3>5. How I Found the Company</h3>
    <p>Discovered through HBS alumni funding news tracking Winter 2024 updates. The company was highlighted among HBS MBA alumni who raised venture capital for healthcare startups.</p>
  </div>

  <div class="strengths-weaknesses">
    <div class="section">
      <h3>Strengths</h3>
      <ul>
        <li><strong>Massive underserved market:</strong> 1.1 billion women worldwide will be in menopause by 2025, yet most receive inadequate care. FemTech for menopause is rapidly growing.</li>
        <li><strong>Strong investor backing:</strong> Seven Seven Six and Flare Capital bring healthcare expertise and network effects.</li>
      </ul>
    </div>
    <div class="section">
      <h3>Weaknesses</h3>
      <ul>
        <li><strong>Competitive landscape:</strong> Faces competition from Midi Health, Gennev, and other menopause-focused startups with more funding.</li>
        <li><strong>Reimbursement challenges:</strong> Many menopause services are not well-covered by insurance, limiting B2C growth.</li>
      </ul>
    </div>
  </div>

  <div class="section">
    <h3>7. Five Questions for the Team</h3>
    <ol class="questions-list">
      <li>What is your current patient volume and monthly growth rate?</li>
      <li>How do you differentiate from Midi Health and other menopause platforms?</li>
      <li>What percentage of revenue comes from B2B (employer) vs B2C channels?</li>
      <li>What is your clinician retention rate and how do you train providers?</li>
      <li>What are your plans for the next funding round and key milestones?</li>
    </ol>
  </div>

  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>

</body>
</html>
